Peptide Manufacturers Stake Out Their Positions | April 27, 2015 Issue - Vol. 93 Issue 17 | Chemical & Engineering News
Volume 93 Issue 17 | pp. 16-19
Issue Date: April 27, 2015

Peptide Manufacturers Stake Out Their Positions

Contract producers gauge the pipeline to size their plants and fill out their services
Department: Business
Keywords: peptide, generic drugs, active pharmaceutical ingredients, contract manufacturing

The hermetic world of bulk peptide manufacturing brought forth news in February when one of the four major players, Bachem, acquired American Peptide, a midsized firm in Sunnyvale, Calif. The deal, which includes a plant not far from Bachem’s U.S. facility in Torrance, Calif., did little to alter the competitive landscape in peptides, however, other than to give the Swiss firm access to production capacity, in case something happens in peptides.

Like others . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society